Short answer · Medically reviewed summary · Last updated: 2026-04-07
Apert Syndrome is caused by a specific genetic mutation in the FGFR2 gene, which leads to the premature fusion of certain skull bones and characteristic malformations of the hands and feet. Genetic Basis of Apert Syndrome The primary cause of Apert Syndrome is a "gain-of-function" mutation in the FGFR2 (Fibroblast Growth Factor Receptor 2) gene located on chromosome 10. Think of this gene as a set of instructions for a protein that acts like a traffic signal for cell growth.
Which are the causes of Apert Syndrome?
Causes of Apert Syndrome explained: genetic and environmental factors, reviewed against medical sources, plus patient perspectives.
Apert Syndrome is caused by a specific genetic mutation in the FGFR2 gene, which leads to the premature fusion of certain skull bones and characteristic malformations of the hands and feet.
Genetic Basis of Apert Syndrome
The primary cause of Apert Syndrome is a "gain-of-function" mutation in the FGFR2 (Fibroblast Growth Factor Receptor 2) gene located on chromosome 10. Think of this gene as a set of instructions for a protein that acts like a traffic signal for cell growth. In individuals with Apert Syndrome, this signal is stuck in the "on" position. This causes the bones in the skull and limbs to fuse together much earlier than they should during fetal development, a process known as craniosynostosis.
Inheritance and Risk Factors
Most cases of Apert Syndrome occur sporadically, meaning they are "de novo" mutations that appear for the first time in an individual with no family history of the condition. While there is a slight increase in the statistical likelihood of having a child with this condition associated with advanced paternal age, there are no known environmental, dietary, or behavioral triggers that cause these mutations. It is not an autoimmune or infectious disease, nor is it caused by anything a parent did or did not do during pregnancy.
Current Research and Understanding
While we have a clear understanding of the specific FGFR2 mutations involved, researchers are still actively investigating why these specific mutations lead to the wide spectrum of severity seen in patients. Ongoing studies focus on how these genetic signals interact with other biological pathways to influence the development of the midface and digits. By mapping the exact molecular pathways, medical researchers hope to develop targeted therapies that might one day modulate these overactive signals.
Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD)
- Orphanet: The portal for rare diseases and orphan drugs
- Online Mendelian Inheritance in Man (OMIM)
- Apert Syndrome Support International
